Work

Supplementary Figure 3 from Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 3 shows that unconjugated Fcµ-Sec has no anti-tumor activity.

DOI: 10.1158/0008-5472.22404023

Authors: Bérengère Vire, Martin Skarzynski, Joshua D. Thomas, Christopher G. Nelson, Alexandre David, Georg Aue, Terrence R. Burke, Christoph Rader, Adrian Wiestner

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361874072

Cites:

Cited by:

Related to: 10